Genspera Inc (OTCQB:GNSZ)

Data as of Jan 30
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

GenSpera, Inc. is a development-stage pharmaceutical company, which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of cancerous tumors, including prostate, brain and other cancers. Its technology platform combines, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that targets the release of the drug only within the tumor. The company was founded by Craig A. Dionne John T. Issacs and Samuel R. Denmeade on November 21, 2003 and is headquartered in San Antonio, TX.

Contact Information

GenSpera, Inc.
2511 North Loop 1604 West
San Antonio Texas 78258
P:(210) 479-8112
Investor Relations:



Individual stakeholders2.88%
Mutual fund holders--
Other institutional--

Top Executives

Craig A. DionneChairman, President, CEO, CFO & CAO
Russell B. RichersonChief Operating Officer & Secretary

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.